VIVI:CSE, TempraMed Technologies Ltd.

VIVI stock overview

TempraMed Technologies Ltd. (VIVI:CSE) closed at $0.500 on October 16, 2026, unchanged on the day. The stock trades 64.3% below its 52-week high of $1.40 and 85.2% above its 52-week low of $0.270. Over the past year, it lost 41.9%. TempraMed Technologies Ltd. is part of the Life Sciences sector.

Key figures

Price
$0.500
Day change
0.00%
Volume
0
Average volume
8,745
Market cap
40M+
52-week range
$0.270 – $1.40
50-day average
$0.410
200-day average
$0.678

Performance

5D 1M 6M 1Y
+2.04% +38.89% -37.50% -41.86%

Price action over the past year

In 252 trading sessions since October 16, 2025, VIVI closed higher on 74 days (29%). Its best day was December 8, 2025 (+27.14%) and its worst was August 27, 2026 (-22.50%). The stock moved 10% or more in a single session 33 times. It opened at least 5% above the previous day's high 19 times.

Recent signals

VIVI news

About TempraMed Technologies Ltd.

TempraMed develops patent protected technology designed to serve a broad range of medical and consumer products TempraMeds primary business focus is revolutionizing injectors for temperature sensitive medications by making them SMART and temperature protected

Similar stocks

Find more stocks like VIVI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.